m6A-centered Drug Response Information
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Extracellular matrix receptor III (CD44)
Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1)
In total 1 mechanisms lead to this potential drug response | ||||
Response Summary | Extracellular matrix receptor III (CD44) is a therapeutic target for BIWA 4. The Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) has potential in affecting the response of BIWA 4 through regulating the expression of Extracellular matrix receptor III (CD44). | [1], [2] | ||
Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC)
In total 1 mechanisms lead to this potential drug response | ||||
Response Summary | Extracellular matrix receptor III (CD44) is a therapeutic target for BIWA 4. The Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC) has potential in affecting the response of BIWA 4 through regulating the expression of Extracellular matrix receptor III (CD44). | [1], [2] | ||
Methyltransferase-like 3 (METTL3)
In total 1 mechanisms lead to this potential drug response | ||||
Response Summary | Extracellular matrix receptor III (CD44) is a therapeutic target for BIWA 4. The Methyltransferase-like 3 (METTL3) has potential in affecting the response of BIWA 4 through regulating the expression of Extracellular matrix receptor III (CD44). | [2], [3] | ||
References